Open Access

Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis

  • Authors:
    • Mitsuyoshi Okazaki
    • Katsunobu Oyama
    • Jun Kinoshita
    • Tomoharu Miyashita
    • Hidehiro Tajima
    • Hiroyuki Takamura
    • Itasu Ninomiya
    • Sachio Fushida
    • Tetsuo Ohta
  • View Affiliations

  • Published online on: July 15, 2019     https://doi.org/10.3892/mco.2019.1897
  • Pages: 343-348
  • Copyright: © Okazaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Totally implantable vascular access devices (TIVADs) are often used to administer chemotherapy by prolonged intravenous infusion. The objective of the present study was to investigate the incidence of long‑term complications and identify risk factors associated with TIVAD placement in patients with gastric cancer. A total of 121 patients with gastric cancer who had undergone 150 TIVAD placement procedures for chemotherapy or supportive care were enrolled in the present retrospective cohort study. A number of risk factors were analyzed, including age, sex, hypertension, diabetes mellitus, history of thrombosis, body mass index, disease stage, and site and purpose of TIVAD. In total, 40 TIVADs (26.7%) developed long‑term complications, of which 27 (18.0%) were infections, seven (4.7%) were catheter‑related deep vein thrombosis (CR‑DVT), and six (4.0%) were obstructions. Chemotherapy was associated with an increased rate of infectious adverse events (odds ratio 2.925; 95% CI, 1.104‑7.750; P=0.031) according to the multivariate analysis. CR‑DVT occurred more frequently in upper arm ports than in chest wall ports; however, this difference was not statistically significant (7.5 vs. 0.0%; P=0.084) according to the univariable analysis. All CR‑DVTs developed in the upper arm sites. Chemotherapy and the upper arm site were associated with long‑term complications in patients with TIVAD. However, further studies are needed to confirm the findings of the present study and to determine the reasons for the high incidence of long‑term complications in these patients.

References

1 

Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J, Mansfield P and Levine M: Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 31:1357–1370. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Turcotte S, Dube S and Beauchamp G: Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg. 30:1605–1619. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Viart H, Combe C, Martinelli T, Thomas J and Hida H: Comparison between implantation costs of peripherally inserted central catheter and implanted subcutaneous ports. Ann Pharm Fr. 73:239–244. 2015.(In French). View Article : Google Scholar : PubMed/NCBI

5 

Goltz JP, Noack C, Petritsch B, Kirchner J, Hahn D and Kickuth R: Totally implantable venous power ports of the forearm and the chest: Initial clinical experience with port devices approved for high-pressure injections. Br J Radiol. 85:e966–e972. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Alexander MD and Morrison HL: Power-injectable ports: Safety during placement, therapeutic use, and contrast administration during computed tomography procedures. J Vasc Access. 13:432–437. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Kock HJ, Pietsch M, Krause U, Wilke H and Eigler FW: Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg. 22:12–16. 1998. View Article : Google Scholar : PubMed/NCBI

8 

Lorch H, Zwaan M, Kagel C and Weiss HD: Central venous access ports placed by interventional radiologists: Experience with 125 consecutive patients. Cardiovasc Intervent Radiol. 24:180–184. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, Beale P, Stockler M, Loneragan R, Dennien B, et al: Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: Institutional experience and review of the literature. Br J Cancer. 91:1045–1049. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F and Andreoni B: Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 9:767–773. 1998. View Article : Google Scholar : PubMed/NCBI

11 

Fragou M, Gravvanis A, Dimitriou V, Papalois A, Kouraklis G, Karabinis A, Saranteas T, Poularas J, Papanikolaou J, Davlouros P, et al: Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: A prospective randomized study. Crit Care Med. 39:1607–1612. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Mori Y, Nagayama S, Kawamura J, Hasegawa S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M, et al: A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Int J Clin Oncol. 21:474–482. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Shiono M, Takahashi S, Kakudo Y, Takahashi M, Shimodaira H, Kato S and Ishioka C: Upper arm central venous port implantation: A 6-Year single institutional retrospective analysis and pictorial essay of procedures for insertion. PLoS One. 9:e913352014. View Article : Google Scholar : PubMed/NCBI

14 

Li Y, Cai Y, Gan X, Ye X, Ling J, Kang L, Ye J, Zhang X, Zhang J, Cai Y, et al: Application and comparison of different implanted ports in malignant tumor patients. World J Surg Oncol. 14:2512016. View Article : Google Scholar : PubMed/NCBI

15 

Pikwer A, Åkeson J and Lindgren S: Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia. 67:65–71. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Todd J: Peripherally inserted central catheters and their use in i.v. therapy. Br J Nurs. 8:140-2, 144–146-8. 1999. View Article : Google Scholar

17 

Ahn DH, Illum HB, Wang DH, Sharma A and Dowell JE: Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: A retrospective analysis of risk factors. J Oncol Pract. 9:e8–e12. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Aw A, Carrier M, Koczerginski J, McDiarmid S and Tay J: Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 130:323–326. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang HM, Lee JL, Kim TW and Kang YK: Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience. Eur J Cancer. 48:492–500. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM and Melton LJ III: Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med. 160:809–815. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Blom JW, Doggen CJ, Osanto S and Rosendaal FR: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 293:715–722. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Liu Y, Gao Y, Wei L, Chen W, Ma X and Song L: Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: A double-center prospective investigation. Ther Clin Risk Manag. 11:153–160. 2015.PubMed/NCBI

23 

Japanese Gastric Cancer Association, . Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Akahane A, Sone M, Ehara S, Kato K, Tanaka R and Nakasato T: Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: A retrospective comparative analysis. Cardiovasc Intervent Radiol. 34:1222–1229. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Kawamura J, Nagayama S, Nomura A, Itami A, Okabe H, Sato S, Watanabe G and Sakai Y: Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer. Int J Clin Oncol. 13:349–354. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Lin WY, Lin CP, Hsu CH, Lee YH, Lin YT, Hsu MC and Shao YY: Right or left? Side selection for a totally implantable vascular access device: A randomised observational study. Br J Cancer. 117:932–937. 2017. View Article : Google Scholar : PubMed/NCBI

27 

Loughran SC and Borzatta M: Peripherally inserted central catheters: A report of 2506 catheter days. JPEN J Parenter Enteral Nutr. 19:133–136. 1995. View Article : Google Scholar : PubMed/NCBI

28 

Tran H, Arellano M, Chamsuddin A, Flowers C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton EF and Khoury HJ: Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma. 51:1473–1477. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, et al: Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer. 22:121–128. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Chen IC, Hsu C, Chen YC, Chien SF, Kao HF, Chang SY, Hu FC and Yeh KH: Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. Ann Oncol. 24:463–468. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Ji L, Yang J, Miao J, Shao Q, Cao Y and Li H: Infections related to totally implantable venous-access ports: Long-term experience in one center. Cell Biochem Biophys. 72:235–240. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Wang TY, Lee KD, Chen PT, Chen MC, Chen YY, Huang CE, Kuan FC, Chen CC and Lu CH: Incidence and risk factors for central venous access port-related infection in Chinese cancer patients. J Formos Med Assoc. 114:1055–1060. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Kuderer NM, Ortel TL and Francis CW: Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol. 27:4902–4911. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Zakai NA, Wright J and Cushman M: Risk factors for venous thrombosis in medical inpatients: Validation of a thrombosis risk score. J Thromb Haemost. 2:2156–2161. 2004. View Article : Google Scholar : PubMed/NCBI

35 

Sallah S, Wan JY and Nguyen NP: Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics. Thromb Haemost. 87:575–579. 2002. View Article : Google Scholar : PubMed/NCBI

36 

Trousseau A: Plegmasia alba dolens. Lectures on clinical medicine. (delivered at the Hotel-Dieu, Paris, Vol. 5. The New Sydenham Society, London). 281–332. 1865.PubMed/NCBI

37 

Wolberg AS, Aleman MM, Leiderman K and Machlus KR: Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg. 114:275–285. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Wojtukiewicz MZ, Sierko E, Klement P and Rak J: The hemostatic system and angiogenesis in malignancy. Neoplasia. 3:371–384. 2001. View Article : Google Scholar : PubMed/NCBI

39 

Larsen AC, Dabrowski T, Frøkjær JB, Fisker RV, Iyer VV, Møller BK, Kristensen SR and Thorlacius-Ussing O: Prevalence of venous thromboembolism at diagnosis of upper gastrointestinal cancer. Br J Surg. 101:246–253. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Quinn DA, Thompson BT, Terrin ML, Thrall JH, Athanasoulis CA, McKusick KA, Stein PD and Hales CA: A prospective investigation of pulmonary embolism in women and men. JAMA. 268:1689–1696. 1992. View Article : Google Scholar : PubMed/NCBI

41 

Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P and Girolami A: Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 154:164–168. 1994. View Article : Google Scholar : PubMed/NCBI

42 

Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM, Gherardi G and Feinleib M: Risk factors for pulmonary embolism: The framingham study. Am J Med. 74:1023–1028. 1983. View Article : Google Scholar : PubMed/NCBI

43 

Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC and Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA. 277:642–645. 1997. View Article : Google Scholar : PubMed/NCBI

44 

Walker AJ, West J, Card TR, Crooks C, Kirwan CC and Grainge MJ: When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data. Blood. 127:849–857. 2016. View Article : Google Scholar : PubMed/NCBI

45 

Debourdeau P, Espié M, Chevret S, Gligorov J, Elias A, Dupré PF, Desseaux K, Kalidi I, Villiers S, Giachetti S, et al: Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: The CAVECCAS study. Cancer Med. 6:2732–2744. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Jones D, Wismayer K, Bozas G, Palmer J, Elliott M and Maraveyas A: The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients. Thromb J. 15:252017. View Article : Google Scholar : PubMed/NCBI

47 

Larsen AC, Frøkjær JB, Fisker RV, Iyer V, Mortensen PB, Yilmaz MK, Møller B, Kristensen SR and Thorlacius-Ussing O: Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer-a clinical prospective study of outcome and prognostic factors. Thromb Res. 135:802–808. 2015. View Article : Google Scholar : PubMed/NCBI

48 

Haddad TC and Greeno EW: Chemotherapy-induced thrombosis. Thromb Res. 118:555–568. 2016. View Article : Google Scholar

49 

Bertoglio S, Faccini B, Lalli L, Cafiero F and Bruzzi P: Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures. J Surg Oncol. 113:708–714. 2016. View Article : Google Scholar : PubMed/NCBI

50 

O'Brien J, Paquet F, Lindsay R and Valenti D: Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol. 10:864–868. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Sud R and Khorana AA: Cancer-associated thrombosis: Risk factors, candidate biomarkers and a risk model. Thromb Res. 123 (Suppl 4):S18–S21. 2009. View Article : Google Scholar : PubMed/NCBI

52 

Shivakumar SP, Anderson DR and Couban S: Catheter-associated thrombosis in patients with malignancy. J Clin Oncol. 27:4858–4864. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 11 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Okazaki, M., Oyama, K., Kinoshita, J., Miyashita, T., Tajima, H., Takamura, H. ... Ohta, T. (2019). Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis. Molecular and Clinical Oncology, 11, 343-348. https://doi.org/10.3892/mco.2019.1897
MLA
Okazaki, M., Oyama, K., Kinoshita, J., Miyashita, T., Tajima, H., Takamura, H., Ninomiya, I., Fushida, S., Ohta, T."Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis". Molecular and Clinical Oncology 11.4 (2019): 343-348.
Chicago
Okazaki, M., Oyama, K., Kinoshita, J., Miyashita, T., Tajima, H., Takamura, H., Ninomiya, I., Fushida, S., Ohta, T."Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis". Molecular and Clinical Oncology 11, no. 4 (2019): 343-348. https://doi.org/10.3892/mco.2019.1897